Dexmedetomidine attenuates lipopolysaccharide-induced proinflammatory response in primary microglia

Journal of Surgical Research

Volumn 179, Issue 1, 2013, Pages

  Peng, Mian ^a   Wang, Yan Lin ^a   Wang, Cheng Yao ^a   Chen, Chang ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Dexmedetomidine; Inflammation; Microglia; Nitric oxide

Indexed keywords

DEXMEDETOMIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CYTOKINE PRODUCTION; DRUG EFFECT; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CELL SURVIVAL; CELLS, CULTURED; DEXMEDETOMIDINE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870680553     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.05.047     Document Type: Article

References (60)

1. E.W. Ely, A. Shintani, and B. Truman Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit JAMA 291 2004 1753
2. M.C. Marshall, and M.D. Soucy Delirium in the intensive care unit Crit Care Nurs Q 26 2003 172
3. A.M. MacLullich, A. Beaglehole, and R.J. Hall Delirium and long-term cognitive impairment Int Rev Psychiatry 21 2009 30
4. A.M. Murray, S.E. Levkoff, and T.T. Wetle Acute delirium and functional decline in the hospitalized elderly patient J Gerontol 48 1993 M181
5. K. Rockwood, S. Cosway, and D. Carver The risk of dementia and death after delirium Age Ageing 28 1999 551
6. K.H. Pitkala, J.V. Laurila, and T.E. Strandberg Prognostic significance of delirium in frail older people Dement Geriatr Cogn Disord 19 2005 158
7. B.C. Munster, E. Aronica, and A.H. Zwinderman Neuroinflammation in delirium: a postmortem case-control study Rejuvenation Res 14 2011 615
8. W.A. van Gool, D. van de Beek, and P. Eikelenboom Systemic infection and delirium: when cytokines and acetylcholine collide Lancet 375 2010 773
9. C. Cunningham, S. Campion, and K. Lunnon Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease Biol Psychiatry 65 2009 304
10. J. Cerejeira, H. Firmino, and A. Vaz-Serra The neuroinflammatory hypothesis of delirium Acta Neuropathol 119 2010 737
11. J.P. Godbout, M. Moreau, and J. Lestage Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system Neuropsychopharmacology 33 2008 2341
12. S. Xiong, H. She, and H. Takeuchi Signaling role of intra-cellular iron in NF-kappaB activation J Biol Chem 278 2003 17646
13. R.B. Banati, J. Gehrmann, and P. Schubert Cytotoxicity of microglia Glia 7 1993 111
14. M. Ebersoldt, T. Sharshar, and D. Annane Sepsis-associated delirium Intensive Care Med 33 2007 941
15. G.A. Garden, and T. Möller Microglia biology in health and disease J Neuroimmune Pharmacol 1 2006 127
16. A. Morandi, C.G. Hughes, and T.D. Girard Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill Chest 140 2011 580
17. J. Gu, J. Chen, and P. Xia Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice Acta Anaesthesiol Scand 55 2011 1272
18. B. Polat, Y. Albayrak, and B. Suleyman Antiulcerative effect of dexmedetomidine on indomethacin-induced gastric ulcer in rats Pharmacol Rep 63 2011 518
19. C.L. Yang, C.H. Chen, and P.S. Tsai Protective effects of dexmedetomidine-ketamine combination against ventilator-induced lung injury in endotoxemia rats J Surg Res 167 2011 e273
20. M. Can, S. Gul, and S. Bektas Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury Acta Anaesthesiol Scand 53 2009 1068
21. T. Taniguchi, Y. Kidani, and H. Kanakura Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats Crit Care Med 32 2004 1322
22. Y.C. Lai, P.S. Tsai, and C.J. Huang Effects of dexmedetomidine on regulating endotoxin-induced up-regulation of inflammatory molecules in murine macrophages J Surg Res 154 2009 212
23. G. Li, S. Sun, and X. Cao LPS-induced degeneration of dopaminergic neurons of substantia nigra in rats J Huazhong Univ Sci Technol Med Sci 24 2004 83
24. J.R. Weinstein, S. Swarts, and C. Bishop Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors Glia 56 2008 16
25. K. Nakajima, M. Shimojo, and M. Hamanoue Identification of elastase as a secretory protease from cultured rat microglia J Neurochem 58 1992 1401
26. Y. Sasaki, M. Takimoto, and K. Oda Endothelin evokes efflux of glutamate in cultures of rat astrocytes J Neurochem 68 1997 2194
27. Y.S. Shibakawa, Y. Sasaki, and Y. Goshima Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide Br J Anaesth 95 2005 803
28. Y.T. Oh, J.Y. Lee, and J. Lee Oleamide suppresses lipopolysaccharide- induced expression of iNOS and COX-2 through inhibition of NF-kappaB activation in BV2 murine microglial cells Neurosci Lett 474 2010 148
29. Y. Song, R. Qu, and S. Zhu Rhynchophylline attenuates LPS-induced pro-inflammatory responses through down-regulation of MAPK/NF-κB signaling pathways in primary microglia Phytother Res 2012 in press
30. J.G. Reves, P.S. Glass, and D.A. Lubarsky Intravenous nonopioid anesthetics R.D. Miller, L.A. Fleisher, R.A. Johns, J.J. Savarese, J. Wiener-kronish, W.L. Young, Miller's Anesthesia 6th ed. 2005 Elsevier Churchill Livingstone Philadelphia 317
31. P. Taepavarapruk, and C. Song Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment J Neurochem 112 2010 1054
32. P. Rada, G.P. Mark, and M.P. Vitek Interleukin-1b decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats Brain Res 550 1991 287
33. J.R. Maldonado, A. Wysong, and P.J. van der Starre Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery Psychosomatics 50 2009 206
34. R.R. Riker, Y. Shehabi, and P.M. Bokesch Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial JAMA 301 2009 489
35. P.P. Pandharipande, R.D. Sanders, and T.D. Girard Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial Crit Care 14 2010 R38
36. R.H. Straub, M. Herrmann, and G. Berkmiller Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control J Neurochem 68 1997 1633
37. M. Maes, A. Lin, and G. Kenis The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products Psychiatry Res 96 2000 245
38. J. Szelenyi, J.P. Kiss, and E.S. Vizi Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha 2- and beta-adrenoceptors in mice J Neuroimmunol 103 2000 34
39. H. Qiao, R.D. Sanders, and D. Ma Sedation improves early outcome in severely septic Sprague Dawley rats Crit Care 13 2009 R136
40. R.M. Venn, A. Bryant, and G.M. Hall Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit Br J Anaesth 86 2001 650
41. D. Memis, S. Hekimoǧlu, and I. Vatan Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients Br J Anaesth 98 2007 550
42. K.P. Mason, S.E. Zgleszewski, and J.L. Dearden Dexmedetomidine for pediatric sedation for computed tomography imaging studies Anesth Analg 103 2006 57
43. K.P. Mason, D. Zurakowski, and S.E. Zgleszewski High dose dexmedetomidine as the sole sedative for pediatric MRI Paediatr Anaesth 18 2008 403
44. P.P. Pandharipande, B.T. Pun, and D.L. Herr Effect of sedation with dexmedetomidine versus lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial JAMA 298 2007 2644
45. M. Venn, J. Newman, and M. Grounds A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit Intensive Care Med 29 2003 201
46. T. Iirola, H. Ihmsen, and R. Laitio Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients Br J Anaesth 108 2012 460
47. T. Iirolal, R. Aantaa, and R. Laitio Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients Critical Care 15 2011 R257
48. T. Kunisawa, A. Kurosawa, and M. Oikawa A high dose of dexmedetomidine using the BIS monitor™ for diagnostic and interventional cardiac catheterization in a toddler with congenital heart disease J Anesth 26 2011 254
49. G.M. Jones, C.V. Murphy, and A.T. Gerlach High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficacy and safety Ann Pharmacother 45 2011 740
50. C.J. Bol, J.P. Vogelaar, and J.W. Mandema Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats J Pharmacol Exp Ther 291 1999 153
51. J.P. Belleville, D.S. Ward, and B.C. Bloor Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation and metabolic rate Anesthesiology 77 1992 1125
52. J.R. Maldonado, A. Wysong, and P.J. Van Der Starre Alpha-2 agonist induced sedation prevents ICU delirium in post-cardiotomy patients J Psychosom Res 58 2005 61
53. J.R. Maldonado, A. Wysong, and P.J. Van Der Starre The role of the novel anesthetic agent dexmedetomidine on reduction of the incidence of ICU delirium in postcardiotomy patients J Psychosom Res 55 2003 150
54. J.L. Teeling, and V.H. Perry Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlyingmechanisms Neuroscience 158 2009 1062
55. V.H. Perry The influence of systemic inflammation oninflammation in the brain: implications for chronicneurodegenerative disease Brain Behav Immun 18 2004 407
56. S. Hofer, J. Steppan, and T. Wagner Central sympatholytics prolong survival in experimental sepsis Crit Care 13 2009 R11
57. I.M. Smith, L.R. Kennedy, and M.H. Regné-Karlsson Adrenergic mechanisms in infection. III. alpha-and beta-receptor blocking agents in treatment Am J Clin Nutr 30 1977 1285
58. K.J. Tracey Physiology and immunology of the cholinergic anti-inflammatory pathway J Clin Invest 117 2007 289
59. D.M. Nance, and V.M. Sanders Autonomic innervation and regulation of the immune system (1987-2007) Brain Behav Immun 21 2007 736
60. T. Taniguchi, A. Kurita, and K. Kobayashi Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats J Anesth 22 2008 221